The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026.
Pitchers and catchers report before long, but expert baseball analysts have already been gazing into crystal balls and ...
🇫🇷 NFL in France: The Saints will play a game in Paris next season, marking the league's first regular-season game in ...
The National Alliance of State and Territorial AIDS Directors estimates 16,000 will lose assistance for the drugs or premiums.
At least 20 states don’t test private wells beyond areas where PFAS problems are suspected. When a well is tainted, it can ...
Today, Infinitus Systems, Inc., healthcare's leading agentic communications partner powering more than 100 million minutes of conversations, launched its new Agentic AI Member Services Suite to ...
Kobrea Exploration Corp. (CSE: KBX) (FSE: F3I) (OTCQB: KBXFF) (“Kobrea” or the “Company”) is pleased to announce that it ...
The University of Salford has announced a new, fully-funded, hands-on National Saturday Club for teenagers to explore social ...
New data show Lp(a) may only raise heart risk if paired with belly fat or inflammation. A simple waist-to-hip ratio could ...
Moneris Solutions Corporation ("Moneris"), a leader in Canadian commerce solutions, today announced two new additions to the Moneris Go commerce suite: the Moneris Go Terminal and Moneris Go PIN Pad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results